Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun 1;22(6):588-590.
doi: 10.1097/PCC.0000000000002718.

Vitamin C, Quo Vadis?

Affiliations
Editorial

Vitamin C, Quo Vadis?

L Nelson Sanchez-Pinto et al. Pediatr Crit Care Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr. Sanchez-Pinto’s institution received money from the National Institutes of Health and the National Institute for Child Health and Human Development. Dr. Wald has disclosed that he does not have any potential conflicts of interest.

Comment on

Similar articles

References

    1. Yanase F, Raman S, Naorungroj T, et al.: Efficacy and Safety of Parenteral High-Dose Vitamin C Therapy in Pediatric Patients: A Scoping Review. Pediatr Crit Care Med 2021; 22:561–571
    1. De Grooth H, Spoelstra-de Man A, Oudemans-van Straaten H: Early plasma vitamin C concentration, organ dysfunction and ICU mortality [abstract 0723]. Intensive Care Med 2014; 40:S199
    1. Borrelli E, Roux-Lombard P, Grau GE, et al.: Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996; 24:392–397
    1. Fowler AA 3rd, Syed AA, Knowlson S, et al.; Medical Respiratory Intensive Care Unit Nursing: Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med 2014; 12:32
    1. Zabet MH, Mohammadi M, Ramezani M, et al.: Effect of high-dose ascorbic acid on vasopressor’s requirement in septic shock. J Res Pharm Pract 2016; 5:94–100